NCT04053270View on ClinicalTrials.gov

Multicentre Phase III Erythropoietic Protoporphyria Study

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 9, 2009

Study Completion Date

December 9, 2009

Conditions
Erythropoietic Protoporphyria
Interventions
DRUG

Afamelanotide

16mg subcutaneous implant

DRUG

Placebo

Placebo subcutaneous implant

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY